Skip to content

August 19, 2024

PBM reform: The end of the beginning

PBM reform: The end of the beginning

The recent release of an interim report by the Federal Trade Commission about what the agency characterizes as “prescription drug middlemen” represents a vindication of sorts for pharmacy advocates who have long contended that PBMs employ business practices that skew the market to their advantage.

The different factors driving workers to stay or leave

The different factors driving workers to stay or leave

In today’s complex environment, understanding the nuances driving associate behavior is not just an option — it’s an imperative. Chain drug stores must explore the strategies that simultaneously promote the factors driving retention while reducing the factors that influence decisions to leave. 

For Rx, GenAI is harbinger of a personalized future

For Rx, GenAI is harbinger of a personalized future

As we delve deeper into this transformative era, it’s essential to understand and embrace the potential of GenAI in revolutionizing patient care, ensuring that those who invest are well informed and poised to reap substantial benefits.